GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clene Inc (FRA:84C) » Definitions » Short-Term Debt

Clene (FRA:84C) Short-Term Debt : €18.43 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clene Short-Term Debt?

Clene's Short-Term Debt for the quarter that ended in Mar. 2024 was €18.43 Mil.

Clene's quarterly Short-Term Debt increased from Sep. 2023 (€8.98 Mil) to Dec. 2023 (€17.88 Mil) and increased from Dec. 2023 (€17.88 Mil) to Mar. 2024 (€18.43 Mil).

Clene's annual Short-Term Debt increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€6.06 Mil) and increased from Dec. 2022 (€6.06 Mil) to Dec. 2023 (€17.88 Mil).


Clene Short-Term Debt Historical Data

The historical data trend for Clene's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clene Short-Term Debt Chart

Clene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
- - - 6.06 17.88

Clene Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.11 - 8.98 17.88 18.43

Clene Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Clene Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Clene's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Clene (FRA:84C) Business Description

Traded in Other Exchanges
Address
6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

Clene (FRA:84C) Headlines

No Headlines